Recent Updates
Recently added Catalysts
NSPR Positive Sentiment Score: 70/100

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

Wednesday, April 3, 2024 1 min read
Key Takeaway: InspireMD, Inc. (Nasdaq: NSPR) will present an update at the 23rd Annual Needham Virtual Healthcare Conference from April 8-11, 2024. The presentation, led by CEO Marvin Slosman, is scheduled for April 10 from 8:00 AM to 8:40 AM ET. InspireMD develops the CGuard™ Embolic Prevention Stent System aimed at preventing strokes and achieving long-term positive outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • InspireMD is participating in a prestigious healthcare conference.
  • The company aims to provide outstanding results with its MicroNet technology.
  • The presentation may enhance visibility and investor interest in InspireMD.

Full Press Release Details

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
Presentation details:
Date: Wednesday, April 10 th
Time: 8:00-8:40 AM ET
Webcast: https://wsw.com/webcast/needham138/nspr/2290730 , or on the Events section of the company’s Investor Relations website at https://www.inspiremd.com/en/events/ .
About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet® technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Chief Financial Officer
craigs@inspiremd.com
Chuck Padala, Managing Director
chuck@lifesciadvisors.com
investor-relations@inspiremd.com

Frequently Asked Questions

When will InspireMD's presentation take place?

The presentation will occur on April 10, 2024.

What time is the InspireMD presentation scheduled?

It is scheduled from 8:00 to 8:40 AM ET.

Where can I watch the InspireMD webcast?

You can watch it at the provided webcast link or on their Investor Relations site.

What technology does InspireMD utilize?

InspireMD uses proprietary MicroNet® technology for carotid stenting.

What is the stock ticker for InspireMD?

InspireMD's common stock is traded on Nasdaq under the ticker NSPR.

Tags: NSPR Viatris Investor Conferences Healthcare InspireMD CGuard stroke prevention healthcare conference
Last updated: Apr 3, 2024